Brimonidine Tartrate

酒石酸溴莫尼定

Also known as: Brimonidine tartrate, 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine tartrate, UK-14304-18, Alphagan, AGN-190342-LF, 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline tartrate

Brimonidine Tartrate (CAS 70359-46-5) is a compound in the Organic Acids category listed in the Jingsj chemical database. It has the molecular formula C15H16BrN5O6 and a molecular weight of 442.221 g/mol. It is also known as Brimonidine tartrate, 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine tartrate and UK-14304-18. Key properties include a melting point of 207-208ºC (dec.), a boiling point of 432.6ºC at 760 mmHg and a flash point of 215.4ºC. It is classified under GHS with signal word Danger and hazard statements H301 — Toxic if swallowed, H315 — Causes skin irritation and H319 — Causes serious eye irritation. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.

CAS No.: 70359-46-5
Jingsj CID: J-1963391-2
Molecular Formula: C₁₅H₁₆BrN₅O₆
Chinese Name: 酒石酸溴莫尼定
Molecular Weight: 442.221 g/mol
Category: Organic Acids
Last updated: 8/21/2026

No offers for this compound yet.

Request a quote

Physicochemical Properties

Melting Point	207-208ºC (dec.)
Boiling Point	432.6ºC at 760 mmHg
Flash Point	215.4ºC
Exact Mass	441.028381
PSA	177.26000
Storage Conditions	-20°C Freezer

GHS Safety & Compliance

Acute ToxicitySignal word: Danger

H301 — Toxic if swallowed
H315 — Causes skin irritation
H319 — Causes serious eye irritation
H335 — May cause respiratory irritation

Activity & Biological Data

Additional Information	[1]. Andorn, A.C., M.A. Carlson, and R.C. Gilkeson, Specific [3H]UK 14,304 binding in human cortex occurs at multiple high affinity states with alpha 2-adrenergic selectivity and differing affinities for GTP. Life Sci, 1988. 43(22): p. 1805-12. [2]. Cambridge, D., UK-14,304, a potent and selective alpha2-agonist for the characterisation of alpha-adrenoceptor subtypes. Eur J Pharmacol, 1981. 72(4): p. 413-5. [3]. Chopin, P., F.C. Colpaert, and M. Marien, Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway. J Pharmacol Exp Ther, 1999. 288(2): p. 798-804.

Additional Information

[1]. Andorn, A.C., M.A. Carlson, and R.C. Gilkeson, Specific [3H]UK 14,304 binding in human cortex occurs at multiple high affinity states with alpha 2-adrenergic selectivity and differing affinities for GTP. Life Sci, 1988. 43(22): p. 1805-12. [2]. Cambridge, D., UK-14,304, a potent and selective alpha2-agonist for the characterisation of alpha-adrenoceptor subtypes. Eur J Pharmacol, 1981. 72(4): p. 413-5. [3]. Chopin, P., F.C. Colpaert, and M. Marien, Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway. J Pharmacol Exp Ther, 1999. 288(2): p. 798-804.

Customs & Trade Information

HS Code	2933990090
Summary	2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Frequently Asked Questions

What is the CAS number of Brimonidine Tartrate?

The CAS number of Brimonidine Tartrate is 70359-46-5.

What are the molecular formula and molecular weight of Brimonidine Tartrate?

Brimonidine Tartrate has molecular formula C15H16BrN5O6 and molecular weight 442.221 g/mol.

Is Brimonidine Tartrate hazardous?

Brimonidine Tartrate has GHS signal word Danger and hazard statements H301 — Toxic if swallowed; H315 — Causes skin irritation; H319 — Causes serious eye irritation.

Data compiled from public chemical databases and supplier catalogs; supplier offers are provided by suppliers.

Last updated: 8/21/2026

How to cite: Jingsj. "Brimonidine Tartrate (CAS 70359-46-5)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-1963391-2 (accessed 2026-10-28).

Data for reference only; verify specifications, grades and regulatory status with suppliers before purchase.